نتائج البحث 311-320 من 23361 لعملية البحث عن B cell lymphomas
... B-Cell Lymphoma (DLBCL). Accelerated vs Standard BEP Chemotherapy for Patients With Intermediate and Poor-risk Metastatic Germ Cell Tumours. Rochester, Minn ...
Find out more about the symptoms, diagnosis and treatment of this type of non-Hodgkin lymphoma.
... B-cell lymphoma 2 (BCL2) inhibitor. A Novel Vaccine (EO2463) as Monotherapy and in Combination, for Treatment of Patients With Indolent Non-Hodgkin Lymphoma.
Safety/Efficacy of MEDI-551 in Combination With Immunomodulating Therapies in Subjects With Aggressive B-cell Lymphomas ... B-cell lymphomas who have failed 1-2 ...
... B-cell Lymphoma (R/R DLBCL). Rochester, Minn. Study B9991011 is a multi-center, international, randomized, open label, 2 component (Phase 1b followed by ...
... B-cell lymphoma 2 (BCL2) inhibitor. A Study to Evaluate Maximizing Anti-PD-1 Therapy By Monitoring T Cell Responses In Melanoma, Lung and Other Cancer Types.
... lymphomas as well as the effectiveness of interventions. A Dose-Escalation and Expansion Study of BGB-16673 in Participants With B-Cell Malignancies.
Treatment of relapsed or refractory mantle cell lymphoma. https://www.uptodate.com/contents/search. Accessed May 2, 2025. B-cell lymphomas. National ...
... lymphoma. Ibrutinib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Rituximab is a monoclonal antibody that may ...
لا تُقدم Mayo Clinic الدعم للشركات أو المنتجات المُعلَّن عنها هنا. لكن تدعم العائدات الإعلانية رسالتنا غير الربحية.
تحقق من هذه الكتب الأكثر مبيعًا والعروض الخاصة على الكتب والنشرات الإخبارية من Mayo Clinic Press.
تساهم التبرّعات، وهي قابلة للخصم الضريبي، في دعم آخر التطورات في الأبحاث وطرق الرعاية لإحداث نقلة نوعية في الطب.